Tight Caloric Control in the Cachectic Oncologic Patient (TiCaCONCO or CoCooN) (TiCaCONCO)
Tight Caloric Control in the Cachectic Oncologic Patient (TiCaCONCO or CoCooN) Can Stabilize Body Weight, Thereby Reducing Morbidity and Mortality: Validation of the Pilot Study - A Randomized Controlled Double-Blind Trial
Sponsor: Baxter Healthcare Corporation
This NA trial investigates Metabolism and Nutrition Disorder and is currently completed. Baxter Healthcare Corporation leads this study, which shows 11 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2022 — Jul 2024 [monthly]
Completed NA
-
May 2021 — Jan 2022 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jan 2021 — May 2021 [monthly]
Active Not Recruiting NA
▶ Show 6 earlier versions
-
Aug 2019 — Jan 2021 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Apr 2019 — Aug 2019 [monthly]
Recruiting NA
-
Mar 2019 — Apr 2019 [monthly]
Recruiting NA
-
Jun 2018 — Mar 2019 [monthly]
Recruiting NA
-
Oct 2017 — Jun 2018 [monthly]
Recruiting NA
-
Mar 2017 — Oct 2017 [monthly]
Recruiting NA
First recorded
Feb 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Baxter Healthcare Corporation
- Nutricia, Inc.
- Universitair Ziekenhuis Brussel
For direct contact, visit the study record on ClinicalTrials.gov .